CCS Medical Deploys Enterprise Agentic AI Platform for Chronic Care Support

CCS Medical, a chronic care management provider focused on diabetes, launched an enterprise-wide agentic artificial intelligence platform designed to support patients across its operations, according to a company announcement on April 28.

The platform, called CeeCee, is already deployed across the organization and is not operating as a pilot. CCS said the system is expected to independently handle 25% of incoming calls within its first four months, while also reducing call-handling times.

The company said the deployment has contributed to savings of more than 30% in annual operating costs. Similar efforts across healthcare providers have focused on measurable operational outcomes, particularly in administrative workflows.

CCS said CeeCee was trained on its proprietary data to deliver personalized support for patients managing chronic conditions. The system consolidates patient records, call history, and clinical context to assist human agents when escalation is required.

Richard Mackey, CTO“CeeCee and our broader agentic AI platform aren’t pilots or a proof of concept - they are enterprise-grade solutions operating across our entire organization right now, autonomously handling patient interactions, accelerating care delivery, and freeing our teams to focus on what they do best,” Richard Mackey, Chief Technology Officer at CCS Medical, said in the announcement.

Automation Focuses on Intake, Documentation, and Call Handling

The platform targets operational bottlenecks tied to documentation and order processing. CCS said CeeCee can identify and close documentation gaps that delay referrals or reorders for continuous glucose monitor (CGM) and insulin pump supplies.

By the end of 2026, the company expects the system to automatically process 70% to 80% of more than 100,000 monthly intake documents. CCS said this would accelerate order fulfillment timelines and reduce delays in patients starting therapy.

The focus on administrative automation aligns with broader healthcare deployments, where AI systems are first applied to billing, intake, and support workflows rather than clinical decision-making.

Enterprise platforms that span multiple operational layers are also emerging across the sector, combining patient interaction, revenue cycle, and care coordination systems.

CCS Positions Platform as Fully Autonomous, Not Pilot-Scale

CCS framed its deployment as a departure from pilot-stage AI implementations. The company said most healthcare AI systems remain limited in scope, while its platform is already operating across core workflows.

“CCS’s platform shows how AI can deliver tangible results at scale today,” Jean-Claude Saghbini, President of Lumeris Technology Solutions and technology advisor for CCS, said in the announcement.

CCS said its system integrates agentic capabilities into patient-facing and backend operations. It manages interactions, processes documentation, and prepares contextual summaries for human staff when intervention is needed.

The use of proprietary datasets to train domain-specific systems is consistent with broader findings that specialized models outperform general-purpose AI in healthcare environments.

The company’s approach also comes as healthcare organizations expand AI deployments faster than regulatory frameworks are evolving, particularly in operational and patient support systems.

CCS said the platform will continue expanding its automation capabilities through 2026 as it increases the share of workflows handled without human intervention.